TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE C

NCT06910943: Study of Choline Chloride for Injection in Adolescent and Adult Patients With Intestinal Failure Receiving Long Term Parenteral Support

Sponsor: Protara Therapeutics · Phase: PHASE2/PHASE3 · Area: CARDIOLOGY_METABOLIC · Target Enrollment: 129 pts

Competing Trials Overlap

12 Active Trials

Excess Burn Exposure

$2,673,264

Rescue Site Savings

+$1,782,176

Unlock Full NCT06910943 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT06910943 Rescue Dossier →